Refine by
Melanoma Equipment & Supplies In Belarus
155 equipment items found
Manufactured by:Xoft, Inc. based inSan Jose, CALIFORNIA (USA)
With the Xoft System, painless, scar-free treatment of NMSC is possible with skin eBx, a form of high dose rate, low energy radiation therapy delivered in minutes over a short series of office visits. While Mohs surgery is considered to be the standard of care for non-melanoma skin cancer (NMSC) treatment, for some patients, surgery is not an option or a ...
Manufactured by:TriStar Technology Group LLC based inWashington, DISTRICT OF COLUMBIA (USA)
Molecular Data: Yes; Approx. # of Donors: 72; Follow Up Data: No; Cores per Donor: 2; Core Size: 1mm; Approx. # of Cores *: 144; TA number: TA3126; List of markers: CD3, CD4, CD8, CD20, CD68, CD163, FOXP3, PD1, PD-L1(22C3); Suitable for (IHC or RNA-ISH): IHC; Suitable for CODEX/GeoMx/CosMx: ...
Manufactured by:NeraCare GmbH based inFrankfurt, GERMANY
Melanoma is a serious form of skin cancer that begins in cells known as melanocytes. While it is less common than basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), melanoma is far more dangerous because of its ability to spread to other organs more rapidly if it not treated at an early ...
Manufactured by:Selleck Chemicals LLC based in, NORTH AMERICA
Imaprelimab (Anti-MUC18 / MCAM / CD146) is a humanized IgG1κ anti-melanoma cell adhesion molecule (MCAM) monoclonal antibody with antineoplastic activity. MW: 145.5 ...
Manufactured by:Selleck Chemicals LLC based in, NORTH AMERICA
Plozalizumab (Anti-CCR2 / CD192) is a specific humanized monoclonal antibody targeting CCR2. Plozalizumab can be used for malignant melanoma research. MW:145.5 ...
Manufactured by:ALL Chemistry Inc. based inMarlton, NEW JERSEY (USA)
RIPK1-IN-7 is a potent and selective inhibitor of RIPK1(Kd of 4 nM and an enzymatic IC50 of 11 nM),andexhibits excellent antimetastasis activity in the experimental B16 melanoma lung metastasis ...
Manufactured by:Selleck Chemicals LLC based in, NORTH AMERICA
Anti-PMEL is a monoclonal antibody targeting human PMEL protein. It is used as a target for antibody drug conjugate (ADC) therapy in melanoma. MW :145.38 ...
Manufactured by:Selleck Chemicals LLC based in, NORTH AMERICA
Glembatumumab is a fully human IgG2 monoclonal antibody directed against the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma. MW: 145.5 ...
Manufactured by:Selleck Chemicals LLC based in, NORTH AMERICA
Anti-PMEL (Genentech anti-PMEL17) is a monoclonal antibody targeting human PMEL protein. It is used as a target for antibody drug conjugate (ADC) therapy in melanoma. MW :145.54 ...
Manufactured by:Selleck Chemicals LLC based in, NORTH AMERICA
Ecromeximab (Anti-GD3) is a human-mouse chimeric IgG1 monoclonal antibody with potential antineoplastic activity that targets ganglioside GD3, a surface antigen expressed on many malignant melanoma cells. It binds to GD3-positive cells, thereby initiating antibody-dependent cytotoxicity against GD3-positive cells. MW: 145.5 ...
Manufactured by:Selleck Chemicals LLC based in, NORTH AMERICA
Cabiralizumab (Anti-CSF1R / M-CSFR / CD115) is an monoclonal antibody (MAb) targeting CSF1R. It can be used in the research of rheumatoid arthritis (RA), melanoma, kidney cancer, or non-small cell lung cancer. MW :146.3 ...
Manufactured by:Reglagene Holding, Inc. based inTucson, ARIZONA (USA)
RGN3118 is a potent, orally administered, blood-brain barrier penetrant therapy that has been optimized for the treatment of high-grade gliomas, such as glioblastoma as well as brain metastases from breast, lung, and melanoma cancers. ...
Manufactured by:Scancell based inOxford, UNITED KINGDOM
Scancell’s lead ImmunoBody cancer vaccine, SCIB1, is being developed for the treatment of patients with metastatic melanoma. SCIB1 incorporates specific epitopes from the proteins gp100 and TRP-2, which were identified from the cloning of T cells from patients who achieved spontaneous recovery from melanoma skin cancers. Both proteins play key roles in the ...
by:Onegene Biotechnology based inSuwon, SOUTH KOREA
OGB23501 is a first-in-class tri-specific tumor microenvironment (TME) immune activator, which simultaneously targets PD-1, CTLA-4, and VEGF. We aim to develop it as a potential backbone therapy for melanoma, NSCLC, HCC, and renal ...
Manufactured by:Biocept based inSan Diego, CALIFORNIA (USA)
his kit detects BRAF V600 mutations in DNA derived from blood plasma or FFPE tissue sections to give insight into cancer characteristics and provide Biomarker status of tumors such as ...
Manufactured by:Selleck Chemicals LLC based in, NORTH AMERICA
Anti-B7-H1 / PD-L1 / CD274 (MDX-1105) is a fully humanized monoclonal antibody targeting B7-H1. It is used in research of advanced melanoma, non-small cell lung carcinoma, renal cell carcinoma, and ovarian cancer. MW :150 ...
Manufactured by:LID Lamps based inLambesc, FRANCE
It is particularly useful for diagnosing erythrasma, fungal infections of the skin, pigmented lesions, bacterial skin infections, as well as pigmentation problems (e.g. vitiligo), melanomas, dermatoses, etc. This portable light is lightweight and easy to use. The power socket is fitted with an electronic ballast and the bulb is protected by a synthetic glass ...
Manufactured by:T-Knife GmbH based inBerlin, GERMANY
TK-8001 is a CD8 TCR-T specific for the Melanoma-associated Antigen Gene-A1, or MAGE-A1. MAGE-A1 is associated with hallmarks of aggressive cancers and poor clinical prognosis, and there is an emerging body of evidence indicating its involvement as a potential driver of tumorigenesis. ...
Manufactured by:Phyton Biotech Ltd based inDelta, BRITISH COLUMBIA (CANADA)
Paclitaxel (sold under trade name Taxol® by Bristol-Myers Squibb) is a very effective plant-derived chemotherapy drug used to treat breast, ovarian, lung, bladder, prostate, melanoma, esophageal, as well as other types of solid tumor cancers. It has also been used to treat Kaposi’s sarcoma. ...
Manufactured by:ViennaLab Diagnostics GmbH based inVienna, AUSTRIA
Determination of BRAF V600 mutational status is recommended in metastatic colorectal cancer (mCRC) at the same time as RAS mutational status for prognostic assessment (and/or potential selection for clinical trials). Testing of patients with metastatic melanoma or advanced non-small cell lung cancer for BRAF V600 mutations prior to treatment is recommended, as BRAF V600 mutation ...